Keywords: gsk, recalls, lapdap, halts, dacart, uk-based, drug

GSK recalls Lapdap and halts Dacart R&D

Article | 10 March 2008

Print This

UK-based drug major GlaxoSmithKline is to stop selling the malaria drug Lapdap (chlorproguanil/dapsone) after study data revealed that its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in